Loading...
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous group of chronic hematological malignancies characterized by dysplasia, ineffective hematopoiesis and a variable risk of progression to acute myeloid leukemia. Sequencing of MDS genomes has identified mutations in genes implicated in RNA splicing,...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Hematology
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3837510/ https://ncbi.nlm.nih.gov/pubmed/24030381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-08-518886 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|